Thermo Fisher (TMO): UBS lifted its rating two notches and slapped a $730 target on the life sciences tools giant, betting the profit-to-price gap finally closes
Rocket Lab (RKLB): Shares popped after the company unveiled a germanium-free solar cell, sidestepping China's stranglehold on the supply chain
Vertiv (VRT): Options strategist Mike Khouw says the AI infrastructure play still has legs despite already surging over 1,000% in five years
